about
Correcting non cephalic presentation with moxibustion: study protocol for a multi-centre randomised controlled trial in general practiceRandomised controlled study in the primary healthcare sector to investigate the effectiveness and safety of auriculotherapy for the treatment of uncomplicated chronic rachialgia: a study protocol.Efficacy of a multifactorial intervention on therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): a randomized controlled trial.Is it possible to diagnose the therapeutic adherence of patients with COPD in clinical practice? A cohort study.Effectiveness of glatiramer acetate compared to other multiple sclerosis therapiesEconomic evaluation of a guided and unguided internet-based CBT intervention for major depression: Results from a multi-center, three-armed randomized controlled trial conducted in primary care.Efficacy of the Treatments Used in Multiple Sclerosis: From Meta-analysis to Number Needed to Treat.Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.Efficacy and safety of a multifactor intervention to improve therapeutic adherence in patients with chronic obstructive pulmonary disease (COPD): protocol for the ICEPOC study.Efficacy of two educational interventions about inhalation techniques in patients with chronic obstructive pulmonary disease (COPD). TECEPOC: study protocol for a partially randomized controlled trial (preference trial).[Response of the author to the letter «Cost-effectiveness study of leflunomide vs. methotrexate»].[A comparison of leflunomide and subcutaneous methotrexate in the treatment of rheumatoid arthritis: an approximation based on the number needed to treat].[Cost-effectiveness analysis of fixed dose antihypertensive drugs].[Cost-effectiveness analysis of tiotropium compared to ipratropium and salmeterol]Cost-utility and budget impact analysis of primary prevention with alendronate of osteoporotic hip fractures in Catalonia.Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C.Effectiveness of surgery in liver metastasis from colorectal cancer: experience and results of a continuous improvement process.[Rational and efficient use of treatment with statins][Effectiveness of a therapeutic practice on overweight in primary care][Determining factors for the use of anxiolytic and hypnotic drugs in the elderly][Improved lung function in cystic fibrosis using mechanical insufflation-exsufflation]
P50
Q33336871-057F6EDD-6FA9-46D1-A9AB-80F51C1971FBQ33349232-07E0BA63-C8B1-496D-86C5-51BB6A5F5C86Q33573085-A81FC960-B5E1-4CC3-A0C2-0FE05F7789D3Q33801644-62603AAA-9512-4BDD-B287-00C37D429948Q35743570-9A1E80AA-B34A-47C3-A47B-CA05723B2DE7Q36291479-0ED128FA-D790-40A5-B011-B2EB20ED993EQ39110666-4023B295-F97A-48C2-9987-B177286E64CDQ39325984-53903AC2-1B15-4C8E-9E11-43549FC784B6Q41878463-A9060BB8-C5B0-4054-A8D3-B3849983D1A3Q41894164-DAFAE900-0379-4D61-9422-832A5E1C6D63Q42728727-B899EB7C-59A4-4AA4-B7C5-EE28AA736F74Q42728741-F2CA8278-8B56-4007-8182-270E2AB85905Q45892831-5E3C9321-26AF-4D61-89A2-2128F69CD19BQ46512235-063634AC-7526-468B-BEC1-7568668175E6Q48016249-7D48922D-21DB-41BD-BBA9-DAFADE4F5631Q48346085-C5A1F067-AD43-4087-A2CD-19F6A5C445DBQ50578298-6D82C5F7-66C1-42DD-820A-3175D247BD88Q80921793-40565ACD-14E6-4AE5-A59F-000FC35B8B66Q81892013-02B5041A-79AC-4F0A-9C82-DCAAEC9BB74DQ87385449-D9CBBA1D-0744-4419-A897-42797A38FE0DQ89373662-A4DBE787-D54A-42A7-8818-30DEA9B9AD85
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Antonio García-Ruiz
@ast
Antonio García-Ruiz
@en
Antonio García-Ruiz
@es
type
label
Antonio García-Ruiz
@ast
Antonio García-Ruiz
@en
Antonio García-Ruiz
@es
altLabel
A.J. Garcia Ruiz
@en
A.J. Garcia-Ruiz
@en
Antonio Garcia Ruiz
@en
Antonio Garcia-Ruiz
@en
Antonio J. Garcia-Ruiz
@en
Antonio J. García Ruiz
@en
Garcia AJ
@en
prefLabel
Antonio García-Ruiz
@ast
Antonio García-Ruiz
@en
Antonio García-Ruiz
@es
P1053
H-4930-2017
P106
P1153
35264047900
P21
P31
P3829
P496
0000-0001-6423-6993